Schools Adopt Face Recognition in the Name of Fighting Covid
By Gregory Barber,
Wired
| 11. 03. 2020
IN JUNE, THE school board in Rio Rancho, New Mexico, was facing a series of votes on the budget for an elaborate and expensive reopening plan. Among the big-ticket items was a tablet designed to screen students and staff for fevers. The devices were sold by a company named OneScreen, which supplies schools with technology including “smart” whiteboards and attendance apps. But this spring, it had pivoted. Its new product, called GoSafe, could scan foreheads for elevated temperatures and detect when students aren’t wearing masks. It also came with a bonus: “top-of-the-line” facial recognition, as a local vendor described it to the school board.
District officials considered this a selling point. The tablets were pricey—$161,000 for 71 devices—even amid the district’s bulk orders of hand sanitizer and protective equipment. But they would get kids through school doors more efficiently than handheld thermometers. The facial recognition tech offered another benefit: The money would not necessarily go to waste as soon as there was a Covid-19 vaccine. The district could use the devices for other things, like taking attendance or preventing intruders...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...